Obamacare has many health care insurers worried
The messy rollout of the insurance exchanges has made it hard for carriers to figure out what business will be like in 2014.
The messy rollout of the insurance exchanges has made it hard for carriers to figure out what business will be like in 2014.
The move includes a $45 million investment for Lilly's operations in Indianapolis, on top of $400 million in investments the company announced over the past two years.
The sheer size puts Indiana University’s Kelley School of Business in a small group of schools with such massive networks. The school has alumni in all 50 states, Washington, D.C., and 106 different countries.
Testosterone replacement drugs, a $1.6 billion market for Eli Lilly and Co. and others, boosted the odds of having a heart attack, stroke or dying by 29 percent in one of the first studies weighing the therapy's cardiovascular risks.
Indianapolis-based Eli Lilly and Co., Bayer AG and Boehringer Ingelheim GmbH are among companies that may consider an offer if the Swiss drugmaker proceeds with the animal-health sale.
U.S. lawmakers, influenced by companies including Indianapolis-based Eli Lilly and Co., Cisco Systems Inc. and Qualcomm Inc., are considering the second set of patent-law changes in three years as the courts try to race ahead of Congress.
With an estimated 8 percent of shoppers using food stamps, the impact will probably be felt most acutely by discount retailers such as Dollar General Corp., Family Dollar Stores Inc. and Wal-Mart Stores, analysts say.
Lawyers for the Federal Home Loan Banks of Boston, Chicago and Indianapolis on Wednesday told a New York Supreme Court judge they are withdrawing from the case against Bank of America Corp.
Economists and politicians on both sides of the aisle have argued for years that streamlining government in Indiana could save millions of dollars, but vested interests and fear of change have stymied real reform.
The National Collegiate Athletic Association lost a bid to dismiss antitrust claims in a lawsuit brought by ex-student athletes over the use of their images and likenesses on television and in video games.
Strong demand for space in Simon’s outlet malls helped boost occupancy at its U.S. properties to 95.5 percent, up from 94.6 percent a year earlier.
The heads of WellPoint Inc., Aetna Inc. and at least 10 other insurers met with the Obama administration Wednesday to discuss correcting flaws in how data from the U.S. health-care marketplaces is transferred to the companies.
Health insurance execs, including WellPoint Inc. CEO Joseph Swedish, will meet with top White House officials Wednesday as the president seeks to contain political damage from the disastrous rollout of Obamacare.
The Indianapolis-based operator of radio stations expects free cash flow after capital expenditures to be about $14 million this year, said CEO Jeffrey Smulyan.
When Peyton Manning plays, ticket prices double on the secondary market and more people watch the game on television. He has as much influence with consumers as Bill Gates and actor Tom Hanks, a celebrity marketing expert says.
Indianapolis-based training firm Adayana Inc. said it sought Chapter 11 bankruptcy reorganization this week after two years of unsuccessfully trying to restructure its debts out of court.
Simon Property Group directors improperly refused to let shareholders vote on changes to the company’s executive-compensation plan that resulted in a $120 million stock award to CEO David Simon, investors’ lawyers argued Monday in court.
Indianapolis Colts quarterback Andrew Luck got an equity stake to join the sports advisory board of MC10, a technology startup that released its first commercial product in July.
Psoriasis is linked to higher rates of heart disease and diabetes, and a third of patients also develop a form of arthritis. About 125 million people worldwide have the skin condition, including 7.5 million Americans.
Eli Lilly and Co. said Thursday that meeting its sale target will be a challenge. It plans to repurchase $5 billion in shares and introduce new diabetes drugs to help navigate through patent losses. Another immediate hurdle: Obamacare.